Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivoGuoshun Luo, Hua Xiang, Yu Chen et al.|Acta Pharmaceutica Sinica B|2020Cited by 77
Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulatorGuoshun Luo, Hua Xiang, Xin Lin et al.|European Journal of Medicinal Chemistry|2020Cited by 9